Clinical Research Directory
Browse clinical research sites, groups, and studies.
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
Sponsor: Groupe Hospitalier Pitie-Salpetriere
Summary
Several Drugs used in routine care in oncology induce rare but often severe or fatal cardiovascular or metabolic side effects. This study will investigate, evaluate, report and treat the cardiovascular side effects of anticancer drugs, through a specific cardiovascular routine checkup and follow-up taking place in several Cardio-oncology programs throughout France. The different including centers will be: Assistance Publique - Hôpitaux de Paris (APHP.6: Pitié-Salpétrière, Saint Antoine and Tenon's hospitals, Paris, France).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
5000
Start Date
2019-03-01
Completion Date
2030-03-01
Last Updated
2026-09-11
Healthy Volunteers
No
Conditions
Interventions
Anti-Cancer Agents
Drugs and treatments used in cancer inducing cardiovascular and metabolic side effects
Locations (3)
AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM
Paris, France, France
AP-HP, Saint-Antoine Hospital, Department of cardiology
Paris, France
AP-HP, Tenon Hospital, Department of Cardiology
Paris, France